Form 8-K · Current report

Veralto 8-K, filed Jul 28, 2026

Filed
CIK
0001967680
Accession no.
0001967680-26-000043
AI-generated summary

Summary

Veralto reported second quarter 2026 sales of $1,474 million, up 7.6% year-over-year with 4.2% core sales growth, and net earnings of $241 million, or $0.98 per diluted share. The company raised its full-year 2026 adjusted earnings per share guidance to $4.35 to $4.43 and its core sales growth guidance to 4.0% to 4.5%, citing strong first-half performance and expected second-half acceleration.

Key points

  • Second quarter sales rose 7.6% year-over-year to $1,474 million, with non-GAAP core sales growth of 4.2%.
  • Net earnings were $241 million, or $0.98 per diluted share; adjusted net earnings were $274 million, or $1.11 per diluted share.
  • Operating cash flow was $340 million and non-GAAP free cash flow $328 million; results include roughly $0.05 per share from recoveries of IEEPA tariffs.
  • Full-year 2026 adjusted EPS guidance was raised to $4.35 to $4.43 and core sales growth guidance to 4.0% to 4.5%, from 3.0% to 4.5%.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 2.02Results of Operations and Financial Condition
  • 9.01Financial Statements and Exhibits

From the filing

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 28, 2026, Veralto Corporation (“Veralto”) issued a press release announcing financial results for the quarter ended July 3, 2026. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Veralto pursuant to Item 2.02 of Form 8-K. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Veralto in Readster

Add Veralto to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.